Back to current studies

Do you have narcolepsy?
​
NeuroTrials Research is conducting a new research study that evaluates the daytime and nighttime effects of XYWAV® (low-sodium oxybate oral solution), in people with narcolepsy (Type 1 or Type 2).
​
All study-related care and study drug will be provided at no cost, and participants will be compensated for time and travel.

YOU MAY QUALIFY IF YOU:

• are 18 to 75 years of age
• ​have a primary diagnosis of narcolepsy (Type 1 or Type 2)
• have symptoms of excessive daytime sleepiness (EDS) if not currently

            taking oxybate medication

• If currently taking oxybate medication, willing to stop for 2 weeks to assess symptoms